Substituted arylamine compounds and methods of treatment
US8604021B2 · kind B2 · utility
2Cited by
14References
15Claims
0Family size
Inventors
Key dates
| Filing date | May 10, 2011 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | May 28, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 5-HT6 receptor antagonists. Novel arylamine compounds and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating obesity, and obesity-related disorders, e.g., cardiovascular disease, digestive disease, respiratory disease, cancer and type II diabetes; and psychological disorders such as schizophrenia, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.